Optibiotix Health Share Discussion Threads

[malreid] 16/5/2018 11:31

Swallowed my pride, cancelled my order and bought at 74 instead of 73.5:)

[monkeywench1] 16/5/2018 11:30

Now the chief Ramper Elrampo is crying. Whatever next.

[elrico] 16/5/2018 11:04

I agree with NOS - We have enough with the resident lunatic fringes without hordes of BBM posting worse nonsensical claptrap we get from Michellemouse and Monkeystench.

[judijudi] 16/5/2018 10:54

Why that nos?

[nerdofsteel] 16/5/2018 10:54

"the droves will cotton on sometime"

Let's hope not, that's usually when it all goes Pete Tong

[trotterstrading] 16/5/2018 10:43

It's going to smash new highs before long - you can't hold back the tide

[bobdown2] 16/5/2018 10:33

As I said aim is a strange place.

[judijudi] 16/5/2018 10:22

The droves will cotton on sometime
Time is on our side (for the moment anyway)

[monkeywench1] 16/5/2018 10:20

Aim market requires actual revenue and profit. Not difficult to understand.

[bobdown2] 16/5/2018 10:19

Totally missed by the aim market again.....aim is a strange place,

[elrico] 16/5/2018 10:17

You would think by now with all this research Michellemouse has been doing over the last 2 years he would have learned a thing or two.

Commercial traction started 12 month ago with LP-LDL with it's priority being B2B not B2c. Michellemouse may want to google what this means!

Each B2B partnership takes time to have products available. Look at the size of the Gallenicum "Stop&Go" products global footprint....is it any wonder it has taken a year in build stock, branding and logistics.

HLH remain the quickest off the mark, with an online presence for both B2c and B2B

It is clear to those not so blind OPTI are signing larger corps and the last 3 are all pharma corps with who is who partners within the pharma industry. Armed with the knowledge OPTI's platforms are pharma based, essentially phase 3 ready.

GoFigure have several high-street listings, further additions have been held back while Christina and Knighton improve the SlimBiome offering. Watch this space.

I have no doubt Michellemouse is feeling invincible because another company he likes to troll, NIPT suckered PI's yesterday.....like all clocks...I'm only surprised he is not using this prediction as a means to scream the same old threat of a placing here. Perhaps I got through to him last time. He won't concede this of course.

[someuwin] 16/5/2018 10:06

I asked Stephen how todays news ties in with the Tata agreements.

Here is his reply...

"This agreement is for LP-LDL, the cholesterol reducing probiotic. The agreements with Tata are to manufacture LPGOS in their new plant and for SlimBiome. The only commonality is India. I can see that investors get confused as we have lots of agreements - with more to come.

India is a massive market with a population of 1.3bn, only second to China with 1.4bn, with many of the population now suffering from western chronic lifestyle diseases. This is a strategic step to access this massive market."

[manc10] 16/5/2018 10:00

vanpuke what happened to 44p

[vanduke] 16/5/2018 09:50

What happened to Slimfast??What happened to P&G???What happened to TATA??

[parsnip1] 16/5/2018 09:45

The accounts to be released next week will likely reflect a start up situation. The Report however may give a Forward Looking Statement, given it will have had a further 6 months non reported activity. This Statement ordinarily builds in forecasts for year end. Whether the Board feel the timing is right to do that remains to be seen. I suspect it may as demand from institutional investors is driven by the meeting/exceeding targets and expectations. Next stop NYSE hopefully

[michaelmouse] 16/5/2018 09:34

Trouble is until products are stocked in major retailers and sell in large quantities then the agreements aren't worth the paper they are written on. If the products don't sell then the agreements will be worthless and not renewed.

That's why it's such high risk while they're generating little revenue and the market cap is already multi-millions. Products need to sell in their millions and until they do then this stock is a massive risk at the current share price

Nobody has answered my question about Tata. Are they still involved or no longer interested given today's exclusive agreement?

Aimho.

[riskybusiness1] 16/5/2018 09:23

Lactobact LDL I'd recommend looking at. As you know Optis model involves building the manufacturing and formulation partners first which clearly preceded the major retailers.

[michaelmouse] 16/5/2018 09:21

A high street retailer please. Go Figure sales from a website don't really count I'm told. In fact last reported results suggested they were selling SFA directly via this website if you look.

Aimho of course.

[riskybusiness1] 16/5/2018 09:20

TATA have nothing to do with LPLDL other than using it to extract LPGOS. The difference really is the application areas they can be used in. Also when combined they both have combined cholesterol reducing effects. Average Joe will be interested in the scientifically proven claims on the packaging. This will be helped due to the microbiome space emerging as healthcare's most promising frontier.You can find all this out yourself though. I'd also rethink your thoughts on Skinbio too.Share price has gone up nearly 30% since you were last trying to spook people. Think Skins up around 60% too.

[joyjoy13] 16/5/2018 09:18

No trades showing up for awhile...?
Wonder if order being filled?

[colinzeal] 16/5/2018 09:17

Have you checked the Go Figure website, mouse? Products have been on sale for a while now lol

[jimmylufc] 16/5/2018 09:13

Nice one rodders - your not such a plonker after all :)

[michaelmouse] 16/5/2018 09:10

Perhaps you could tell me a retailer that stocks products with Opti's technology in them and I'll have a look at the labelling to see if it makes more sense? Any UK or global retailer will do.

TIA

[trotterstrading] 16/5/2018 09:05

Not could - there WILL be. Cath is the science but make not mistake SoH is the commercial driver